$PCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pacira BioSciences, Inc.. Get notifications about new insider transactions in Pacira BioSciences, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 28,885 | 46,505 | 83,190 | |
| Jan 12 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 41.97 | 885 | 37,143 | 100,446 | 101.3 K to 100.4 K (-0.87 %) |
| Jan 12 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 41.03 | 4,628 | 189,887 | 101,331 | 106 K to 101.3 K (-4.37 %) |
| Jan 12 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 39.96 | 23,372 | 933,945 | 105,959 | 129.3 K to 106 K (-18.07 %) |
| Jan 12 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 28,885 | 46,505 | 129,331 | 100.4 K to 129.3 K (+28.76 %) |
| Jan 05 2018 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | Chief Operating Off ... | Option Exercise | A | 46.35 | 60,000 | 2,781,000 | 60,000 | |
| Dec 18 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.70 | 340 | 14,858 | 10,442 | 10.8 K to 10.4 K (-3.15 %) |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | M | 25.37 | 7,857 | 199,332 | 0 | |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | M | 25.37 | 2,143 | 54,368 | 7,857 | |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 40.00 | 7,857 | 314,280 | 21,312 | 29.2 K to 21.3 K (-26.94 %) |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Buy | M | 25.37 | 7,857 | 199,332 | 29,169 | 21.3 K to 29.2 K (+36.87 %) |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 40.01 | 2,143 | 85,741 | 21,312 | 23.5 K to 21.3 K (-9.14 %) |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Buy | M | 25.37 | 2,143 | 54,368 | 23,455 | 21.3 K to 23.5 K (+10.06 %) |
| Nov 20 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Sell | S | 41.11 | 850 | 34,942 | 16,823 | 17.7 K to 16.8 K (-4.81 %) |
| Nov 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 28,885 | 46,505 | 112,075 | |
| Nov 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 38.97 | 1,900 | 74,043 | 100,279 | 102.2 K to 100.3 K (-1.86 %) |
| Nov 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 38.32 | 56,985 | 2,183,665 | 102,179 | 159.2 K to 102.2 K (-35.80 %) |
| Nov 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 28,885 | 46,505 | 159,164 | 130.3 K to 159.2 K (+22.17 %) |
| Nov 13 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 41.60 | 1,000 | 41,603 | 6,795 | 5.8 K to 6.8 K (+17.26 %) |
| Aug 24 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 36.15 | 1,044 | 37,741 | 3,518 | 4.6 K to 3.5 K (-22.88 %) |
| Aug 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 36.75 | 3,461 | 127,192 | 21,312 | 24.8 K to 21.3 K (-13.97 %) |
| Aug 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 28,885 | 46,505 | 11,810 | |
| Aug 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 36.37 | 28,885 | 1,050,547 | 130,279 | 159.2 K to 130.3 K (-18.15 %) |
| Aug 17 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 28,885 | 46,505 | 159,164 | 130.3 K to 159.2 K (+22.17 %) |
| Aug 16 2017 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Buy | P | 37.13 | 100 | 3,713 | 100 | 0 to 100 |
| Jul 26 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 15,000 | 24,150 | 140,960 | |
| Jul 26 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 15,000 | 24,150 | 130,279 | 115.3 K to 130.3 K (+13.01 %) |
| Jun 27 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 15,000 | 24,150 | 155,960 | |
| Jun 27 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 15,000 | 24,150 | 115,059 | 100.1 K to 115.1 K (+14.99 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Option Exercise | A | 44.20 | 8,144 | 359,965 | 8,144 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,357 | 0 | 3,845 | 2.5 K to 3.8 K (+54.54 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 11,000 | 0 | 24,773 | 13.8 K to 24.8 K (+79.87 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 44.20 | 9,000 | 397,800 | 9,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 4,864 | 364 to 4.9 K (+1,236.26 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 44.20 | 81,000 | 3,580,200 | 81,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 40,500 | 0 | 100,059 | 59.6 K to 100.1 K (+68.00 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | A | 44.20 | 17,500 | 773,500 | 17,500 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Grant | A | 0.00 | 8,750 | 0 | 13,593 | 4.8 K to 13.6 K (+180.67 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 44.20 | 6,000 | 265,200 | 6,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,000 | 0 | 10,063 | 7.1 K to 10.1 K (+42.47 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 44.20 | 17,500 | 773,500 | 17,500 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 44.20 | 15,000 | 663,000 | 15,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 7,500 | 0 | 17,313 | 9.8 K to 17.3 K (+76.43 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.10 | 10,000 | 441,000 | 10,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 11,000 | 0 | 20,982 | 10 K to 21 K (+110.20 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,357 | 0 | 7,490 | 6.1 K to 7.5 K (+22.13 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,357 | 0 | 23,537 | 22.2 K to 23.5 K (+6.12 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,357 | 0 | 5,145 | 3.8 K to 5.1 K (+35.82 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,357 | 0 | 5,795 | 4.4 K to 5.8 K (+30.58 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,357 | 0 | 4,562 | 3.2 K to 4.6 K (+42.34 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,357 | 0 | 4,845 | 3.5 K to 4.8 K (+38.90 %) |
| Jun 09 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 44.37 | 1,119 | 49,650 | 7,063 | 8.2 K to 7.1 K (-13.68 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 43.32 | 1,877 | 81,314 | 13,773 | 15.7 K to 13.8 K (-11.99 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 43.32 | 4,311 | 186,757 | 59,559 | 63.9 K to 59.6 K (-6.75 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 43.32 | 1,966 | 85,169 | 25,118 | 27.1 K to 25.1 K (-7.26 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.32 | 601 | 26,036 | 8,182 | 8.8 K to 8.2 K (-6.84 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Sell | S | 43.32 | 767 | 33,227 | 9,813 | 10.6 K to 9.8 K (-7.25 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Sell | S | 43.32 | 768 | 33,271 | 9,982 | 10.8 K to 10 K (-7.14 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | M | 10.81 | 11,979 | 129,493 | 0 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | M | 10.52 | 5,937 | 62,457 | 0 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | M | 9.25 | 3,125 | 28,906 | 0 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 50.86 | 21,041 | 1,070,145 | 15,650 | 36.7 K to 15.7 K (-57.35 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Buy | M | 10.81 | 11,979 | 129,493 | 36,691 | 24.7 K to 36.7 K (+48.47 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Buy | M | 10.52 | 5,937 | 62,457 | 24,712 | 18.8 K to 24.7 K (+31.62 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Buy | M | 9.25 | 3,125 | 28,906 | 18,775 | 15.7 K to 18.8 K (+19.97 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 20,000 | 109,800 | 15,251 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 51.20 | 20,000 | 1,024,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 20,000 | 109,800 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 17,627 | 96,772 | 35,251 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 2,373 | 3,821 | 0 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.97 | 4,997 | 194,733 | 27,084 | 32.1 K to 27.1 K (-15.58 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.39 | 15,003 | 575,965 | 32,081 | 47.1 K to 32.1 K (-31.86 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 17,627 | 96,772 | 47,084 | 29.5 K to 47.1 K (+59.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 2,373 | 3,821 | 29,457 | 27.1 K to 29.5 K (+8.76 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 15,000 | 82,350 | 15,610 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 38.81 | 1,300 | 50,453 | 63,870 | 65.2 K to 63.9 K (-1.99 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 38.37 | 13,700 | 525,669 | 65,170 | 78.9 K to 65.2 K (-17.37 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 15,000 | 82,350 | 78,870 | 63.9 K to 78.9 K (+23.49 %) |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 32.35 | 16,000 | 517,600 | 16,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 32.35 | 60,000 | 1,941,000 | 60,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 32.35 | 6,000 | 194,100 | 6,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 32.35 | 16,000 | 517,600 | 16,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 32.35 | 10,000 | 323,500 | 10,000 | |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 15,000 | 82,350 | 30,610 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 37.76 | 1,800 | 67,968 | 63,637 | 65.4 K to 63.6 K (-2.75 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 37.21 | 13,200 | 491,172 | 65,437 | 78.6 K to 65.4 K (-16.79 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 15,000 | 82,350 | 78,637 | 63.6 K to 78.6 K (+23.57 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 20,000 | 32,200 | 2,373 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 36.50 | 20,000 | 730,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 20,000 | 32,200 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Oct 07 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 30,000 | 48,300 | 40,695 | |
| Oct 07 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 30,000 | 48,300 | 63,637 | 33.6 K to 63.6 K (+89.19 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 15,000 | 82,350 | 45,610 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 45.32 | 15,000 | 679,800 | 33,637 | 48.6 K to 33.6 K (-30.84 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 15,000 | 82,350 | 48,637 | 33.6 K to 48.6 K (+44.59 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 15,877 | 25,562 | 22,373 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 9,123 | 14,688 | 0 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 45.21 | 25,000 | 1,130,250 | 27,084 | 52.1 K to 27.1 K (-48.00 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 15,877 | 25,562 | 52,084 | 36.2 K to 52.1 K (+43.85 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 9,123 | 14,688 | 36,207 | 27.1 K to 36.2 K (+33.68 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 8,750 | 0 | 15,650 | 6.9 K to 15.7 K (+126.81 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 40.34 | 10,000 | 403,400 | 10,000 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 40.34 | 66,250 | 2,672,525 | 66,250 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 33,125 | 0 | 33,410 | 285 to 33.4 K (+11,622.81 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 40.34 | 32,500 | 1,311,050 | 32,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Grant | A | 0.00 | 16,250 | 0 | 26,754 | 10.5 K to 26.8 K (+154.70 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 40.34 | 6,250 | 252,125 | 6,250 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,125 | 0 | 8,453 | 5.3 K to 8.5 K (+58.65 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 8,750 | 0 | 10,250 | 1.5 K to 10.3 K (+583.33 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,488 | 0 | 6,133 | 4.6 K to 6.1 K (+32.03 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 8,750 | 0 | 10,250 | 1.5 K to 10.3 K (+583.33 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,488 | 0 | 6,133 | 4.6 K to 6.1 K (+32.03 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,488 | 0 | 22,180 | 20.7 K to 22.2 K (+7.19 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,488 | 0 | 3,788 | 2.3 K to 3.8 K (+64.70 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,488 | 0 | 4,438 | 3 K to 4.4 K (+50.44 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,488 | 0 | 3,205 | 1.7 K to 3.2 K (+86.66 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,488 | 0 | 3,488 | 2 K to 3.5 K (+74.40 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,488 | 0 | 2,488 | 1,000 to 2.5 K (+148.80 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 47.20 | 600 | 28,319 | 6,900 | 7.5 K to 6.9 K (-8.00 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.90 | 517 | 24,765 | 5,328 | 5.8 K to 5.3 K (-8.85 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.90 | 100 | 4,790 | 5,845 | 5.9 K to 5.8 K (-1.68 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.20 | 321 | 15,151 | 5,945 | 6.3 K to 5.9 K (-5.12 %) |